DIVIS LABORATORIES
Back to Balance Sheet
|
DIVIS LABORATORIES Last 5 Year Net Block History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Block | ₹5,442 Cr | ₹4,739 Cr | ₹4,722 Cr | ₹4,325 Cr | ₹3,704 Cr |
What is the latest Net Block ratio of DIVIS LABORATORIES ?
| Year | Net Block |
|---|---|
| Mar2025 | ₹5,442 Cr |
| Mar2024 | ₹4,739 Cr |
| Mar2023 | ₹4,722 Cr |
| Mar2022 | ₹4,325 Cr |
| Mar2021 | ₹3,704 Cr |
How is Net Block of DIVIS LABORATORIES Trending?
| Years | Net Block | % Change | |
|---|---|---|---|
| Mar2025 | ₹5,442 Cr | 14.83 | |
| Mar2024 | ₹4,739 Cr | 0.36 | |
| Mar2023 | ₹4,722 Cr | 9.18 | |
| Mar2022 | ₹4,325 Cr | 16.77 | |
| Mar2021 | ₹3,704 Cr | - | |
Compare Net Block of peers of DIVIS LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DIVIS LABORATORIES | ₹158,705.3 Cr | -1.5% | -3.4% | 9.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹418,528.0 Cr | -3.1% | 1.6% | 5.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹142,457.0 Cr | -4.1% | -1.2% | 40.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,339.0 Cr | -1.5% | -0.9% | 16.8% | Stock Analytics | |
| CIPLA | ₹100,056.0 Cr | -5.7% | -7.8% | -13.2% | Stock Analytics | |
| MANKIND PHARMA | ₹82,617.3 Cr | -6.4% | -3% | -4.5% | Stock Analytics | |
DIVIS LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DIVIS LABORATORIES | -1.5% |
-3.4% |
9.3% |
| SENSEX | -2.4% |
-10.9% |
0.2% |
You may also like the below Video Courses